S.C. Helios S.A.

BVB:HEAL Stock Report

Market Cap: RON 30.4m

S.C. Helios Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for S.C. Helios.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Basic Materials earnings growth17.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article • Nov 21

Even With A 33% Surge, Cautious Investors Are Not Rewarding S.C. Helios S.A.'s (BVB:HEAL) Performance Completely

S.C. Helios S.A. ( BVB:HEAL ) shareholders have had their patience rewarded with a 33% share price jump in the last...
Analysis Article • Nov 12

We Like These Underlying Return On Capital Trends At S.C. Helios (BVB:HEAL)

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Analysis Article • Oct 07

S.C. Helios S.A.'s (BVB:HEAL) Price Is Right But Growth Is Lacking After Shares Rocket 30%

S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Analysis Article • Oct 07

S.C. Helios S.A. (BVB:HEAL) Held Back By Insufficient Growth Even After Shares Climb 30%

S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Analysis Article • Jun 12

S.C. Helios (BVB:HEAL) Is Experiencing Growth In Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article • Apr 26

Further Upside For S.C. Helios S.A. (BVB:HEAL) Shares Could Introduce Price Risks After 29% Bounce

Those holding S.C. Helios S.A. ( BVB:HEAL ) shares would be relieved that the share price has rebounded 29% in the last...
Analysis Article • Apr 21

S.C. Helios (BVB:HEAL) Seems To Use Debt Rather Sparingly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Feb 25

Take Care Before Jumping Onto S.C. Helios S.A. (BVB:HEAL) Even Though It's 25% Cheaper

The S.C. Helios S.A. ( BVB:HEAL ) share price has fared very poorly over the last month, falling by a substantial 25...
Analysis Article • Dec 30

S.C. Helios S.A. (BVB:HEAL) Stock Rockets 29% But Many Are Still Ignoring The Company

S.C. Helios S.A. ( BVB:HEAL ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...
Analysis Article • Nov 10

S.C. Helios S.A. (BVB:HEAL) Stock Rockets 192% But Many Are Still Ignoring The Company

S.C. Helios S.A. ( BVB:HEAL ) shareholders would be excited to see that the share price has had a great month, posting...
Analysis Article • Nov 03

S.C. Helios (BVB:HEAL) Has A Rock Solid Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Analysis Article • Sep 03

A Piece Of The Puzzle Missing From S.C. Helios S.A.'s (BVB:HEAL) Share Price

With a price-to-earnings (or "P/E") ratio of 4.8x S.C. Helios S.A. ( BVB:HEAL ) may be sending very bullish signals at...
Analysis Article • May 21

Not Many Are Piling Into S.C. Helios S.A. (BVB:HEAL) Stock Yet As It Plummets 27%

S.C. Helios S.A. ( BVB:HEAL ) shareholders that were waiting for something to happen have been dealt a blow with a 27...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as S.C. Helios has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

BVB:HEAL - Analysts future estimates and past financials data (RON Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025326N/AN/AN/A
9/30/2025325N/AN/AN/A
6/30/2025325N/AN/AN/A
3/31/2025335N/AN/AN/A
1/1/202534566N/A
10/1/2024345N/AN/AN/A
6/30/2024354N/AN/AN/A
3/31/2024353N/AN/AN/A
1/1/202435355N/A
10/1/2023363N/AN/AN/A
6/30/2023372N/AN/AN/A
3/31/2023373N/AN/AN/A
1/1/202338377N/A
9/30/2022353N/AN/AN/A
6/30/2022323N/AN/AN/A
3/31/2022303N/AN/AN/A
1/1/202229322N/A
10/1/2021303N/AN/AN/A
6/30/2021312N/AN/AN/A
3/31/2021292N/AN/AN/A
1/1/202128266N/A
10/1/2020262N/AN/AN/A
6/30/2020241N/AN/AN/A
3/31/2020241N/AN/AN/A
1/1/202025233N/A
10/1/2019252N/AN/AN/A
6/30/2019251N/AN/AN/A
3/31/2019251N/AN/AN/A
12/31/2018251N/A1N/A
9/30/2018261N/AN/AN/A
6/30/2018281N/AN/AN/A
3/31/2018281N/AN/AN/A
1/1/2018281N/A7N/A
10/1/2017271N/AN/AN/A
6/30/2017261N/AN/AN/A
3/31/2017261N/AN/AN/A
1/1/2017251N/A3N/A
10/1/2016251N/AN/AN/A
6/30/2016241N/AN/AN/A
3/31/2016251N/AN/AN/A
1/1/2016251N/A4N/A
10/1/2015251N/AN/AN/A
6/30/2015241N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if HEAL's forecast earnings growth is above the savings rate (6.8%).

Earnings vs Market: Insufficient data to determine if HEAL's earnings are forecast to grow faster than the RO market

High Growth Earnings: Insufficient data to determine if HEAL's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if HEAL's revenue is forecast to grow faster than the RO market.

High Growth Revenue: Insufficient data to determine if HEAL's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if HEAL's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/12 11:47
End of Day Share Price 2026/04/24 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

S.C. Helios S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.